✦ LIBER ✦

High-Dose Radiotherapy With or Without Androgen Deprivation Therapy for Intermediate-Risk Prostate Cancer: Cancer Control and Toxicity Outcomes

✍ Scribed by Scott Edelman; Stanley L. Liauw; Peter J. Rossi; Sherrie Cooper; Ashesh B. Jani

Book ID: 118456970
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 340 KB
Volume: 83
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2011.10.036

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of Androgen Deprivation Therapy o

Impact of Androgen Deprivation Therapy on Men with Intermediate Risk Prostate Cancer Treated with Dose Escalated Radiotherapy

✍ M.H. Stenmark; F.Y. Feng; D.A. Hamstra 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Androgen deprivation therapy in combinat

Androgen deprivation therapy in combination with radiotherapy for high-risk clinically localized prostate cancer

✍ Tsutomu Nishiyama 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 433 KB

Intermediate- and High-Risk Prostate Can

Intermediate- and High-Risk Prostate Cancer: A Plea for High-Dose, High-Precision Intensity-Modulated Radiotherapy With a Modulated Duration of Androgen Deprivation Therapy

✍ Michel Bolla 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Comparative risk-adjusted mortality outc

Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer

✍ Michael Froehner 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 1 views

Comparative risk-adjusted mortality outc

Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer

✍ Axel Madlung; Mathew Simcock; Pirus Ghadjar 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 1 views

## Results of a Prospective Phase 2 Trial With great interest we read the article by Brown et al, who reported the results of a phase 2 study using gemcitabine and cisplatin in patients with advanced endometrial cancer. 1 Although we recognize the reported impressive activity of this regimen, we b

Comparative risk-adjusted mortality outc

Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer

✍ Matthew R. Cooperberg; Andrew J. Vickers; Jeanette M. Broering; Peter R. Carroll 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 360 KB 👁 2 views